IRIS - Res&Arch Institutional Research Information System - Research & Archive

ANGELI, FABIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.916
AS - Asia 1.467
EU - Europa 1.402
SA - Sud America 254
AF - Africa 32
OC - Oceania 7
Continente sconosciuto - Info sul continente non disponibili 2
Totale 5.080
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.881
SG - Singapore 707
IE - Irlanda 254
UA - Ucraina 216
HK - Hong Kong 203
RU - Federazione Russa 203
BR - Brasile 202
IT - Italia 192
CN - Cina 183
SE - Svezia 183
VN - Vietnam 172
FI - Finlandia 86
DE - Germania 82
FR - Francia 79
IN - India 38
GB - Regno Unito 32
TR - Turchia 26
KR - Corea 22
AR - Argentina 21
BD - Bangladesh 17
PK - Pakistan 17
CA - Canada 16
AT - Austria 13
IQ - Iraq 13
UZ - Uzbekistan 11
CH - Svizzera 10
ID - Indonesia 10
NL - Olanda 9
VE - Venezuela 9
MX - Messico 8
ZA - Sudafrica 8
BE - Belgio 7
PL - Polonia 7
EC - Ecuador 6
JO - Giordania 6
JP - Giappone 6
TN - Tunisia 6
CO - Colombia 5
ES - Italia 5
KZ - Kazakistan 4
MA - Marocco 4
MY - Malesia 4
NZ - Nuova Zelanda 4
PY - Paraguay 4
AE - Emirati Arabi Uniti 3
DZ - Algeria 3
EG - Egitto 3
GR - Grecia 3
IL - Israele 3
LB - Libano 3
LT - Lituania 3
PH - Filippine 3
AU - Australia 2
AZ - Azerbaigian 2
BG - Bulgaria 2
BO - Bolivia 2
BY - Bielorussia 2
CL - Cile 2
CZ - Repubblica Ceca 2
EE - Estonia 2
HU - Ungheria 2
JM - Giamaica 2
KG - Kirghizistan 2
LY - Libia 2
ME - Montenegro 2
NI - Nicaragua 2
PE - Perù 2
SA - Arabia Saudita 2
TH - Thailandia 2
UG - Uganda 2
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BF - Burkina Faso 1
CI - Costa d'Avorio 1
CR - Costa Rica 1
CU - Cuba 1
CY - Cipro 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
EU - Europa 1
GE - Georgia 1
GT - Guatemala 1
HR - Croazia 1
KE - Kenya 1
KH - Cambogia 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
LU - Lussemburgo 1
MG - Madagascar 1
NR - Nauru 1
OM - Oman 1
PA - Panama 1
PS - Palestinian Territory 1
RO - Romania 1
RS - Serbia 1
SY - Repubblica araba siriana 1
TT - Trinidad e Tobago 1
UY - Uruguay 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 5.080
Salva come PNG Salva come JPEG
Città #
Singapore 494
Chandler 295
Dublin 254
Hong Kong 202
San Jose 169
San Mateo 140
Jacksonville 136
Ashburn 118
Dong Ket 107
Altamura 91
Boardman 90
Santa Clara 79
Medford 69
Princeton 69
Lawrence 67
Moscow 63
Beijing 61
Lauterbourg 60
Wilmington 57
Perugia 48
Ann Arbor 24
Helsinki 23
Ho Chi Minh City 23
New York 23
Seoul 22
Andover 21
Los Angeles 20
São Paulo 18
The Dalles 17
Hanoi 16
Saint Petersburg 16
Des Moines 15
Izmir 11
Norwalk 11
Chennai 10
Atlanta 9
Brooklyn 9
Falls Church 9
Munich 9
Rio de Janeiro 9
San Paolo di Civitate 9
Redwood City 8
Shanghai 8
Belo Horizonte 7
Denver 7
Amman 6
Amsterdam 6
Brussels 6
Chicago 6
Phoenix 6
Rome 6
Tokyo 6
Woodbridge 6
Baghdad 5
Columbus 5
Council Bluffs 5
Frankfurt am Main 5
Johannesburg 5
Lahore 5
London 5
Montreal 5
Porto Alegre 5
Tashkent 5
Toronto 5
Vienna 5
Warsaw 5
Amelia 4
Ankara 4
Caxias do Sul 4
Goiânia 4
Karachi 4
Mexico City 4
New Delhi 4
Nuremberg 4
Orem 4
Piscataway 4
San Francisco 4
Seattle 4
Asunción 3
Bauru 3
Cagliari 3
Caracas 3
Curitiba 3
Dhaka 3
Falkenstein 3
Guayaquil 3
Houston 3
Kaifeng 3
Kuala Lumpur 3
Manchester 3
Medellín 3
Mumbai 3
Ottawa 3
Piracicaba 3
Redmond 3
Ribeirão Preto 3
Salvador 3
San Diego 3
Tunis 3
Turku 3
Totale 3.250
Salva come PNG Salva come JPEG
Nome #
Aliskiren versus ramipril in hypertension. 117
Adverse prognostic significance of new diabetes in treated hypertensive subjects 115
Prehypertension and Cardiometabolic Syndrome 107
Choice of ACE inhibitor combinations in hypertensive patients with type 2 diabetes: update after recent clinical trials. 106
Beta-blockers and risk of all-cause mortality in non-cardiac surgery. 105
Day-Night Dip and Early-Morning Surge in Blood Pressure in Hypertension: Prognostic Implications 105
Above which blood pressure level does the risk of atrial fibrillation increase? 104
Angiotensin-converting enzyme inhibitors 97
Improved cardiovascular risk stratification by a simple ECG index in hypertension 96
New-onset diabetes, antihypertensive treatment, and outcome 94
Angiotensin-converting enzyme inhibitors, angiotensin receptor blockers and protection from stroke. 91
Optimal therapy in hypertensive subjects with diabetes mellitus 91
Amlodipine and celecoxib for treatment of hypertension and osteoarthritis pain 91
Meta-Analysis of effectiveness or lack thereof of angiotensin-converting enzyme inhibitors for prevention of heart failure in patients with systemic hypertension 91
Effects of intensive blood pressure reduction on myocardial infarction and stroke in diabetes: a meta-analysis in 73,913 patients 90
Microalbuminuria and hypertension. 88
Atrial fibrillation and mortality in patients with acute myocardial infarction: a systematic overview and meta-analysis. 87
Exploring the optimal combination therapy in hypertensive patients with diabetes mellitus. 86
Blood pressure lowering in diabetic patients. 86
Long-term outcome in patients with non-valvular atrial fibrillation on dabigatran: a prospective cohort study 85
Betabloccanti e ipertensione arteriosa. Evidence-based medicine o eccessivo accanimento? 85
Comparison between angiotensin-converting enzyme inhibitors and angiotensin receptor blockers on the risk of myocardial infarction, stroke and death: a meta-analysis. 84
Angiotensin receptor blockers in hypertension. New insights from Japan. 83
Beyond blood pressure: evidence for cardiovascular, cerebrovascular, and renal protective effects of renin-angiotensin system blockers. 82
Usual versus tight control of systolic blood pressure in non-diabetic patients with hypertension (Cardio-Sis): an open-label randomised trial. 81
Cystatin C and risk of mortality among patients undergoing percutaneous coronary intervention 81
Impact of blood pressure variability on cardiac and cerebrovascular complications in hypertension 80
Optimizing the definition of dippers and nondippers: is a 70-86% full glass empty? 80
Home Blood Pressure Measurements Will Not Replace 24-Hour Ambulatory Blood Pressure Monitoring. 80
Lowering blood pressure with β-blockers in peripheral artery disease: the importance of comorbidity 79
New-onset diabetes in treated hypertensive patients 77
Quali novità nella gestione dell’ipertensione arteriosa dopo le recenti linee guida europee e nordamericane? 77
"From apennines to andes:" does body mass index affect the relationship between age and blood pressure? 74
Home Blood Pressure Measurements Will or Will Not Replace 24-Hour Ambulatory Blood Pressure Measurement. 73
Comparative assessment of angiotensin receptor blockers in different clinical settings. 73
Pharmacokinetic, pharmacodynamic and clinical evaluation of aliskiren for hypertension treatment. 73
Validation of the A&D UA-774 (UA-767Plus) device for self-measurement of blood pressure. 73
Modernization and hypertension: is the link changing? 72
Tight blood pressure control in diabetes: evidence-based review of treatment targets in patients with diabetes. 71
Modern treatment of patients at risk: stilla HOPE for ACE inhibitors? 71
Risk Prediction Models for Hypertensive Disorders of Pregnancy: Role of 12-Lead Electrocardiography 69
Safety and efficacy of aliskiren in the treatment of hypertension and associated clinical conditions. 68
Hypertrophy at ECG and its regression during treatment survey (HEART survey). Rationale, design and baseline characteristics of patients. 68
Telmisartan for the reduction of cardiovascular morbidity and mortality. 67
Finding a place for aliskiren in the wide spectrum of blood pressure lowering agents. 67
Diuretic treatment of hypertension 66
PK/PD evaluation of fimasartan for the treatment of hypertension Current evidences and future perspectives 65
The voltage of R wave in lead aVL improves risk stratification in hypertensive patients without ECG left ventricular hypertrophy. 64
Perioperative beta blockade: the debate continues. 62
White-coat hypertension in adults. 62
Statins in acute coronary syndrome: very early initiation and benefits. 61
Short- and Long-Term Incidence of Stroke in White-Coat Hypertension 58
Good news for beta-blockers in perioperative medicine. 57
Pharmacokinetic evaluation and clinical utility of azilsartan medoxomil for the treatment of hypertension. 57
Role and prognostic value of individual ambulatory blood pressure components in chronic kidney disease 56
Hypertension around the world: new insights from developing countries. 54
Hypertension and the J-curve phenomenon: implications for tight blood pressure control 53
What to Do When Blood Pressure Is Between 130/80 and 139/89 mm Hg? 53
Multivariable analysis in cerebrovascular research: practical notes for the clinician. 52
Neutrophil count and ambulatory pulse pressure as predictors of cardiovascularadverse events in postmenopausal women with hypertension 52
More than a REASON to use arterial stiffness as risk marker and therapeutic target in hypertension 51
Prognostic value of lipoprotein fractions in essential hypertension. 51
Protein intake in type 1 diabetes: putting controversies into perspectives. 51
Fixed-dose combination therapy in hypertension: cons. 50
Very early initiation of statin therapy and mortality in patients with acute coronary syndrome. 49
Unattended compared to traditional blood pressure measurement in patients with rheumatoid arthritis: a randomised cross-over study 49
II monitoraggio ambulatoriale della pressione arteriosa nella pratica clinica 47
Mecanismos de la hipertrofia ventricular izquierda en la hipertensión: Más que solo la presión arterial 46
Tight Blood Pressure Control Saves Lives in Hypertensive Patients With Chronic Kidney Disease 46
Is hydrochlorothiazide more effective on LVH in nonresponders to losartan than in those to atenolol? 45
Totale 5.177
Salva come PNG Salva come JPEG
Categoria #
all - tutte 25.138
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 25.138
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021182 0 0 0 0 0 0 0 0 0 21 46 115
2021/2022472 9 86 18 35 11 5 1 167 4 3 61 72
2022/2023969 71 218 8 65 89 87 3 62 310 4 37 15
2023/2024325 24 44 17 5 5 1 58 2 38 10 46 75
2024/2025765 4 76 29 51 105 35 50 34 146 42 151 42
2025/20261.629 118 115 120 181 236 138 336 99 178 108 0 0
Totale 5.177